Clinical considerations on the use of concomitant therapy in the treatment of acne

Journal of Dermatological Treatment

Volumn 19, Issue 4, 2008, Pages 199-209

  Alexis, Andrew F ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Acne; Acne vulgaris; Benzoyl peroxide; Concomitant therapy; Lesion reduction; Oral antibiotic; Topical antibiotic; Topical retinoid

Indexed keywords

ADAPALENE; ANTI ACNE AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; MACROLIDE; MINOCYCLINE; RETINOIC ACID; RETINOID; RETINOID DERIVATIVE; RETINOL; TAZAROTENE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; AUTOIMMUNE HEPATITIS; BURN; BURNING SENSATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMEDO; CONTROLLED CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; DYSPEPSIA; ERYTHEMA; EVENING DOSAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LOW LEVEL LASER THERAPY; LUPUS LIKE SYNDROME; MONOTHERAPY; MORNING DOSAGE; NAUSEA; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROPHYLAXIS; PROPIONIBACTERIUM ACNES; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN IRRITATION; SKIN PIGMENTATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGINA CANDIDIASIS; VESTIBULAR DISORDER; VOMITING;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; HUMANS; PHOTOTHERAPY; RETINOIDS;

EID: 48249107389     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630802132635     Document Type: Review

References (56)

1. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl): S1-S37.
2. Longshore SJ, Hollandsworth K. Acne vulgaris: One treatment does not fit all. Cleve Clin J Med. 2003;70:670-80.
3. Jansen T, Grabbe S, Plewig G. [Clinical variants of acne.] Hautarzt. 2005;56:1018-26.
4. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(3 Suppl): S200-10.
5. Webster GF. The pathophysiology of acne. Cutis. 2005;76(2 Suppl): 4-7.
6. Goulden V. Guidelines for the management of acne vulgaris in adolescents. Paediatr Drugs. 2003;5:301-13.
7. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651-63.
8. Katsambas AD, Stefanaki C, Cunliffe WJ. Guidelines for treating acne. Clin Dermatol. 2004;22:439-44.
9. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004;292:726-35.
10. Leyden JJ, Marples RR, Mills OH, Kligman AM. Tretinoin and antibiotic therapy in acne vulgaris. South Med J. 1974;67:20-5.
11. Christiansen JV, Gadborg E, Ludvigsen K, Konstman Meier CH, Norholm A, Osmundsen PE, et al. Topical vitamin A acid (Airol) and systemic oxytetracycline in the treatment of acne vulgaris. A controlled clinical trial. Dermatologica. 1974;149:121-8.
12. Fulton JE Jr, Farzad-Bakshandeh A, Bradley S. Studies on the mechanism of action to topical benzoyl peroxide and vitamin A acid in acne vulgaris. J Cutan Pathol. 1974;1:191-200.
13. Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813-31.
14. Bergfeld WF. The pathophysiology of acne vulgaris in children and adolescents, part 2: Tailoring treatment. Cutis. 2004;74:189-92.
15. Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol. 2005;4:41-7.
16. Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Arsonnaud S, Kang S. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: A multicenter, investigator-blind, randomized, controlled study. Skinmed. 2005;4:138-46.
17. Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: A multicenter, double-blind, randomized, parallel-group study. Arch Dermatol. 2006;142:605-12.
18. Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Kerrouche N, Arsonnaud S, et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: A randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol. 2006;142:597-602.
19. Thiboutot DM, Gollnick HP. Treatment considerations for inflammatory acne: Clinical evidence for adapalene 0.1% in combination therapies. J Drugs Dermatol. 2006;5:785-94.
20. Cunliffe WJ, Meynadier J, Alirezai M, George SA, Coutts I, Roseeuw DI, et al. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol. 2003;49(3 Suppl): S218-26.
21. Tan AW, Tan HH. Acne vulgaris: A review of antibiotic therapy. Expert Opin Pharmacother. 2005;6:409-18.
22. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: A worldwide problem. Dermatology. 2003;206:54-6.
23. Tanghetti E. The impact and importance of resistance. Cutis. 2007;80(1 Suppl): 5-9.
24. Toyoda M, Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology. 1998;196:130-4.
25. Wolf JE Jr, Kaplan D, Kraus SJ, Loven KH, Rist T, Swinyer LJ, et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: A multicenter, randomized, investigator-blinded study. J Am Acad Dermatol. 2003;49(3 Suppl): S211-17.
26. Bowman S, Gold M, Nasir A, Vamvakias G. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: A randomized, blinded study. J Drugs Dermatol. 2005;4:611-18.
27. Draelos ZD, Tanghetti EA. Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy. Cutis. 2002;69(2 Suppl): 20-9.
28. Zhang JZ, Li LF, Tu YT, Zheng J. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat. 2004;15:372-8.
29. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: A meta-analysis of five randomized trials. Br J Dermatol. 1998;139(Suppl 52): 48-56.
30. Cunliffe WJ, Danby FW, Dunlap F, Gold MH, Gratton D, Greenspan A. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Eur J Dermatol. 2002;12:350-4.
31. Nyirady J, Grossman RM, Nighland M, Berger RS, Jorizzo JL, Kim YH, et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat. 2001;12:149-57.
32. Thiboutot D, Gold MH, Jarratt MT, Kang S, Kaplan DL, Millikan L, et al. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001;68(4 Suppl): 10-19.
33. Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J. Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris: A double-blind randomized trial. Cutis. 2002;69(2 Suppl): 12-19.
34. Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris. Cutis. 2002;69(2 Suppl): 4-11.
35. Shalita A, Miller B, Menter A, Abramovits W, Loven K, Kakita L. Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: A multicenter, double-blind, randomized, parallel-group study. J Drugs Dermatol. 2005;4:153-8.
36. Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Am J Clin Dermatol. 2001;2:33-9.
37. BenzaClin [package insert]. Bridgewater, NJ: Dermik Laboratories; 2006.
38. Duac [package insert]. Coral Gables, FL: Steifel Laboratories; 2006.
39. Benzamin [package insert]. Bridgewater, NJ: Dermik Laboratories; 2006.
40. Del Rosso JQ. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. J Drugs Dermatol. 2007;6:616-22.
41. Kircik L. Community-based trial results of combination clindamycin 1%-benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. Cutis. 2007;80(1 Suppl): 10-14.
42. Tanghetti E, Abramovits W, Solomon B, Loven K, Shalita A. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: A multicenter, double-blind, randomized parallel-group trial. J Drugs Dermatol. 2006;5:256-61.
43. Taylor SC. Utilizing combination therapy for ethnic skin. Cutis. 2007;80(1 Suppl): 15-20.
44. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol. 1998;139(Suppl 52):8-11.
45. Nyirady J, Lucas C, Yusuf M, Mignone P, Wisniewski S. The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis. 2002;70:295-8.
46. Nighland M, Yusuf M, Wisniewski S, Huddleston K, Nyirady J. The effect of simulated solar UV irradiation on tretinoin in tretinoin gel microsphere 0.1% and tretinoin gel 0.025%. Cutis. 2006;77:313-16.
47. Dosik JS, Gilbert RD, Arsonnaud S. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies. Skinmed. 2006;5:219-23.
48. Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791-9.
49. Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:899-905.
50. Leyden JJ, Krochmal L, Yaroshinsky A. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54:73-81.
51. Schlessinger J, Menter A, Gold M, Leonardi C, Eichenfield L, Plott RT, et al. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:607-15.
52. Nouri K, Ballard CJ. Laser therapy for acne. Clin Dermatol. 2006;24:26-32.
53. Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Phototherapy in the treatment of acne vulgaris: What is its role? Am J Clin Dermatol. 2004;5:211-16.
54. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol. 2006;24:16-25.
55. Alexiades-Armenakas M. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne. J Drugs Dermatol. 2006;5:45-55.
56. Fernandez-Guarino M, Garcia-Morales I, Harto A, Montull C, Perez-Garcia B, Jaen P. [Photodynamic therapy: new indications.] Actas Dermosifiliogr. 2007;98:377-95.